Benitec Biopharma Inc (BNTC)
9.40
-0.09
(-0.95%)
USD |
NASDAQ |
May 23, 13:09
Benitec Biopharma Total Assets (Quarterly): 15.00M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.00M |
December 31, 2023 | 21.35M |
September 30, 2023 | 27.05M |
June 30, 2023 | 4.464M |
March 31, 2023 | 8.22M |
December 31, 2022 | 11.90M |
September 30, 2022 | 18.12M |
June 30, 2022 | 5.973M |
March 31, 2022 | 10.06M |
December 31, 2021 | 14.01M |
September 30, 2021 | 17.84M |
June 30, 2021 | 21.38M |
March 31, 2021 | 13.43M |
December 31, 2020 | 15.51M |
September 30, 2020 | 8.916M |
June 30, 2020 | 11.59M |
Date | Value |
---|---|
June 30, 2019 | 19.24M |
December 31, 2018 | 21.32M |
June 30, 2018 | 15.68M |
March 31, 2018 | 11.45M |
December 31, 2017 | 13.85M |
September 30, 2017 | 16.09M |
June 30, 2017 | 17.42M |
March 31, 2017 | 19.24M |
December 31, 2016 | 14.36M |
September 30, 2016 | 15.78M |
June 30, 2016 | 14.85M |
March 31, 2016 | 20.73M |
December 31, 2015 | 20.60M |
June 30, 2015 | 19.57M |
December 31, 2014 | 24.82M |
June 30, 2014 | 24.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.464M
Minimum
Jun 2023
27.05M
Maximum
Sep 2023
14.36M
Average
14.01M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
Galectin Therapeutics Inc | 25.89M |
TG Therapeutics Inc | 373.32M |
BioVie Inc | 31.77M |
Jaguar Health Inc | 55.39M |
Entero Therapeutics Inc | 91.13M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.499M |
Shareholders Equity (Quarterly) | 11.50M |